What results can I expect from semaglutide?

In clinical trials of semaglutide 2.4 mg weekly (Wegovy), average weight loss was around 10–15% of body weight over ~68 weeks when combined with diet and activity, with individual variation.

Is AOD-9604 safer than semaglutide?

Semaglutide’s safety profile is well‑characterised in large trials and real‑world use, with mainly gastrointestinal side effects and known rare risks. AOD-9604 lacks comparable large‑scale safety data, and product quality varies widely in the grey market.

How do I access semaglutide or discuss alternatives?

You’ll need a prescription from a qualified clinician. Many Australians use telehealth weight‑management services. Use the contact form on this page to request guidance, or see our Weight Loss Injections Australia and GLP‑1 Australia guides.

AOD-9604 vs Semaglutide: Fat Loss Claims vs Approved GLP-1 Therapy

Q: Which is better for weight loss: AOD-9604 or semaglutide?

Semaglutide has robust, peer‑reviewed clinical trial evidence and TGA approval for weight management (Wegovy) and diabetes (Ozempic). AOD-9604 does not have comparable high‑quality human data demonstrating meaningful weight loss and is not TGA‑approved for obesity.

Q: Is AOD-9604 legal in Australia?

AOD-9604 is not an approved medicine for weight loss in Australia. Any therapeutic use occurs under unapproved medicine pathways and requires a registered health professional. Grey‑market supply and personal importation carry legal and safety risks.

At a glance: AOD-9604 vs semaglutide

Regulatory status: Semaglutide is TGA‑approved (Ozempic for type 2 diabetes; Wegovy for weight management). AOD-9604 is not approved for obesity.
Evidence for weight loss: Semaglutide shows consistent, clinically meaningful weight loss in large trials. AOD-9604 lacks robust human evidence for significant weight loss.
How they work: AOD-9604 is an hGH fragment with proposed lipolysis effects; semaglutide is a GLP‑1 receptor agonist that reduces appetite, improves satiety and glycaemia.
Safety: Semaglutide has a well‑characterised safety profile; AOD-9604 safety data are limited and grey‑market quality control is a concern.
Access in Australia: Semaglutide requires a prescription; AOD-9604 use occurs via unapproved pathways—be cautious of online sellers.

Check your options with a clinician

What they are and how they work

AOD-9604

AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 176–191). It is marketed for “fat burning” via proposed mechanisms that increase lipolysis and reduce lipogenesis. Despite online claims, high‑quality human trials showing meaningful, sustained weight loss are lacking.

Learn more: What Is AOD-9604? · AOD-9604 Benefits · AOD-9604 for Fat Loss

Semaglutide

Semaglutide is a GLP‑1 receptor agonist that reduces appetite, slows gastric emptying and improves blood glucose. It is TGA‑approved as Ozempic (type 2 diabetes) and Wegovy (chronic weight management). Weight loss is primarily driven by lower energy intake and improved satiety.

Learn more: What Is Semaglutide? · Semaglutide for Weight Loss · GLP‑1 Australia Guide

Ask about medical weight‑loss options

Evidence for weight loss: how strong is it?

AOD-9604: Publicly available human data are limited and mixed. There is no body of large, peer‑reviewed randomised trials demonstrating clinically meaningful weight loss versus placebo. Claims often rely on proposed mechanisms or small studies rather than robust outcomes.
Semaglutide: Multiple large randomised trials (e.g., STEP program) show average weight loss around 10–15% with 2.4 mg weekly alongside lifestyle changes, with individual variation and known side‑effect profiles.

If your goal is medically supervised, evidence‑based weight loss, semaglutide currently has far stronger support than AOD-9604.

Get help deciding based on your history

Expected results and timeline

AOD-9604: No consistent, validated timeline for meaningful weight loss in humans.
Semaglutide: Appetite changes can appear within weeks; average weight loss accrues across months, with plateaus common. See: Semaglutide Results Timeline.

Talk to a provider about realistic timelines

Safety and side effects

AOD-9604

Safety data in large, long‑term human studies are limited.
Product quality varies widely outside regulated channels; contamination and mislabelling risks exist in the grey market.
Sporting bodies have previously treated unapproved substances cautiously; always check current rules if you are an athlete.

Deep dives: AOD-9604 Side Effects · Counterfeit Peptides Australia

Semaglutide

Common: nausea, vomiting, diarrhoea/constipation, reduced appetite—often dose‑dependent and transient.
Serious but uncommon: gallbladder issues, pancreatitis; rodent thyroid C‑cell tumour signal—contraindicated with personal/family history of medullary thyroid carcinoma or MEN2.
See: Semaglutide Side Effects · Ozempic Side Effects · Wegovy Side Effects

Discuss safety and eligibility

Legality and access in Australia

AOD-9604: Not TGA‑approved for weight loss. Any therapeutic use occurs under unapproved medicine pathways with a registered health professional. Personal importation and online “research” sales carry seizure and safety risks. Learn more: Is AOD-9604 Legal in Australia? · Buy AOD-9604 Australia.
Semaglutide: Prescription‑only medicine. Ozempic (diabetes) and Wegovy (weight management) are TGA‑approved; supply constraints may occur. Learn more: Buy Semaglutide Australia · Semaglutide Prescription Australia.

Find legitimate medical access

Cost and ongoing care

Pricing varies by clinic, brand, dose and follow‑up. Evidence‑based care includes eligibility screening, dose titration, side‑effect management and support for lifestyle change.

Semaglutide: See Semaglutide Cost Australia, Wegovy Cost Australia, Ozempic Cost Australia.
AOD-9604: See AOD-9604 Cost Australia. Be cautious with low‑cost grey‑market sources.

Provider comparisons: Peptide Clinics Australia · Online Peptide Clinic Australia · Peptide Clinic Cost Australia

Get help comparing costs and access

Who each may suit

Semaglutide (Wegovy): Adults with obesity, or overweight with weight‑related comorbidities, when combined with lifestyle changes and medical supervision.
AOD-9604: Given the lack of robust human evidence and unapproved status, many clinicians do not recommend it as a primary weight‑loss therapy.

See if GLP‑1 therapy is appropriate for you

Common red flags in marketing

Before/after photos with no clinical context or timeframes.
“Research chemical” sales pitched as medical treatments without prescriptions.
Claims that AOD-9604 equals or exceeds GLP‑1 results without peer‑reviewed human data.

Helpful resources: Peptide Advertising Laws Australia · Peptide Reviews Guide · Before & After Guide

Alternatives and related options

Other GLP‑1/GIP medicines: What Is Tirzepatide? · Tirzepatide for Weight Loss
Amylin‑based research: What Is Cagrilintide? · Cagrilintide for Weight Loss
Education hubs: Weight Loss Injections Australia · GLP‑1 Australia Guide · Peptide Therapy Australia

Get help choosing an evidence‑based path

Frequently asked questions

Which is better for weight loss: AOD-9604 or semaglutide?

Semaglutide. It has strong clinical evidence and TGA approval. AOD-9604 lacks robust human weight‑loss data.

Can I use AOD-9604 and semaglutide together?

Do not combine therapies without medical supervision. Discuss risks, benefits and evidence with a qualified prescriber.

Is AOD-9604 legal in Australia?

It is not TGA‑approved for obesity. Any therapeutic use would be under unapproved pathways. Be cautious with online sellers and import claims.

What side effects should I expect with semaglutide?

Mostly gastrointestinal symptoms during dose titration. Review detailed risks here: Semaglutide Side Effects.

How do I get prescribed semaglutide in Australia?

Assessment by a clinician is required. Start here: Semaglutide Prescription Australia or use the form below.

Ask a question

Final takeaway

For “aod 9604 vs semaglutide,” semaglutide is the evidence‑based, TGA‑approved option for medical weight management. AOD-9604 remains an unapproved compound without comparable human efficacy data. If you are pursuing safe, sustainable weight loss, speak with a qualified provider and prioritise treatments supported by robust trials.

Get help starting safely

Get guidance from a legitimate Australian provider

Use this form to request a call or email about evidence‑based weight‑management options, including GLP‑1 therapy and alternatives. A clinician or care coordinator can discuss eligibility, costs and next steps.

Prefer to read first? See our hubs: Weight Loss Injections Australia · GLP‑1 Australia Guide